M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...
The firm says that with paltusotine’s Phase 3 for carcinoid syndrome set to kick off before year-end, Crinetics unveils a new asset for neuroendocrine tumors. Crinetics again demonstrated its “drug ...